“…The following antibodies, plasmids and reagents used in the study were listed below with working dilution or concentration, catalog number, and manufactory company: actin antibody (Western blot, WB ‐ 1:1000, sc8432, Santa cruz), α‐tubulin antibody (WB—1:1000; sc‐5286; Santa cruz), γ‐tubulin antibody (Immunofluorescence; IF—1:100; sc‐17788; Santa cruz), Cdc42 antibody (WB—1:1000; sc‐87; Santa cruz), GFP antibody (WB—1:2000; 11814460001; Roche), GRASP65 antibody (IF—1:1000; ab174834; Abcam), HA antibody (WB—1:2000; H3553; Sigma), HURP, HURP m122, and HURP nm122 antibody (Chiu et al, 2022), JMJD6 antibody (WB ‐ 1:500, sc‐32740, Santa cruz), NF‐кB antibody (IF ‐ 1:100, sc‐8008, Santa cruz), V5 antibody (WB ‐ 1:2000, GTX628592, Gene Tex), PADI4 antibody (WB—1:1000; #32493; Signalway), SAS6 antibody (WB—1:1000; sc376836; Santa Cruz), p EGFP (#13031; addgene), EGFP‐HURP WT, 122 K,122 F (Chiu et al, 2022), V5‐JMJD6 (B. Chang et al, 2007), p NF‐кB ‐Luc reporter plasmid (Chen et al, 2015), HA‐HURP (Yu et al, 2005), BFA (1 μg/ml; B6542, Sigma), ARF6 inhibitor SecinH3 (25 μM; CAS 853625‐60‐2; Santa Cruz), Cdc42 inhibitor ML141 (25 μM; SML0407; Sigma), NF‐кB inhibitor IV (50 μM; 481412; MERCK), PMA (1 μg/ml; P1585; Sigma), puromycin (2 μg/ml; ant‐pr‐5b; Invivogen). 293T and HeLa were from ATCC.…”